Insmed Inc. buy UBS Group AG
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€42.39
Performance (%)
181.72%
End price
28.02.25
€75.50
Summary
This prediction ended on 28.02.25 with a price of €75.50. The BUY prediction by UBS_Group_AG for Insmed Inc. saw massive gains of 181.72%. UBS_Group_AG has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -6.250% | -6.250% | 137.410% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten